Mirosława Püsküllüoğlu

16PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCreative arts, media and communication curriculum and pedagogyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 12, 2026
The Prognostic Potential of PD-L1, PD-1, CD3, CD4, and CD8 Expression in Patients with Head and Neck Cancers Depending on HPV16 Infection.

|May 27, 2026
Immune-Related Adverse Events of Cemiplimab Therapy in Advanced Cervical Cancer-Data from the Polish-Czech Cervical Cancer Immunotherapy Group (PCCIG-01) with a Review of the Literature.

|May 19, 2026
Serum fatty acid profiles across clinicopathologic heterogeneity in breast cancer: an exploratory study.

|Feb 02, 2026
Combined positive score status in metastatic triple-negative breast cancer patients treated with sacituzumab govitecan: associated clinical characteristics and testing patterns in a Central European cohort.

Karolina Winsko-Szczęsnowicz, Małgorzata Pieniążek, Anna Polakiewicz-Gilowska

|Sep 27, 2025
Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis.

Małgorzata Pieniążek, Anna Polakiewicz-Gilowska, Manuela Las-Jankowska

|Aug 22, 2025
Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort.

Małgorzata Pienia̧żek, Anna Polakiewicz-Gilowska, Manuela Las-Jankowska

Pageof 3

Frequent Collaborators

5 joint publications

Aleksandra Grela-Wojewoda

5 joint publications

Renata Pacholczak-Madej

3 joint publications

Małgorzata Pieniążek

2 joint publications

Stanisława Bazan-Socha